27.3 C
New York
Thursday, June 11, 2026

Tag: business model

PONY AI Inc. Accelerates Gen-7 Robotaxi Production with over 200 Newly Produced, On Track to Scale Up 1,000-Vehicle Fleet by Year End

NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in achieving large-scale commercialization of autonomous mobility, today announced its unaudited financial results for the second quarter ended June 30, 2025.

China Literature Announces 2025 Interim Results

HONG KONG, Aug. 12, 2025 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual...

Nauticus Robotics Announces Results for the Second Quarter of 2025

Revenue Momentum Endures; Market Diversification Continues   HOUSTON, Aug. 11, 2025 /PRNewswire/ -- Nauticus Robotics, Inc. ("Nauticus" or "Company") (NASDAQ: KITT), a leading innovator in...

Consolidated Water Reports Second Quarter 2025 Results

GEORGE TOWN, Cayman Islands, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, reported results for the second quarter ended June 30, 2025. All comparisons are to the same prior year period unless otherwise noted.

Gevo Reports Second Quarter 2025 Financial Results

Achieves Positive Net Income in the Second Quarter and Positive Adjusted EBITDAfor the Second Quarter and Six Months Ended June 30, 2025 

Franco-Nevada Reports Record Q2 2025 Results

Acquisitions Increase Growth Outlook (in U.S. dollars unless otherwise noted) TORONTO, Aug. 9, 2025 /PRNewswire/ - "I am very pleased with our record financial results this...

EQT to acquire South Korea’s leading AI-enabled HR Tech Platform, Remember

Remember has rapidly grown into a leading AI-powered HR tech platform used by the vast majority of South Korea's professional workforce, solidifying its position...

WOOF IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Petco Health and Wellness Company, Inc. Investors with Losses in Excess of $100K to Secure Counsel...

NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) between January 14, 2021 and June 5, 2025, both dates inclusive (the “Class Period”), of the important August 29, 2025 lead plaintiff deadline.

Digital Brands Enters into Securities Purchase Agreement for $11.225 Million Private Placement with Select Investors

Austin, TX, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. (OTCQX: DBGI) (“DBG” or the “Company”), a publicly traded company specializing in eCommerce and Fashion, today announced that it has entered into a private investment in public equity (“PIPE”) financing agreement with select investors (the “Investors”) for gross proceeds of approximately $11,225,000.00, after deducting placement agent fees and offering expenses.

Freedom Holding Corp. reports 17% revenue growth in Q1 FY2026 driven by strong insurance and banking segments

NEW YORK, Aug. 9, 2025 /PRNewswire/ -- Freedom Holding Corp. (Nasdaq: FRHC), a diversified financial services and technology group, today announced its unaudited financial results...

DDB Technology Redefines Innovation by Transforming Business Models, Not Just Products

NEW YORK, Aug. 9, 2025 /PRNewswire/ -- At a time when the term "innovation" is often confined to gadgets and features, DDB Technology, LLC...

Femasys Announces Second Quarter Financial Results for 2025

-- Continued Progress on Regulatory Approvals and Global Commercialization of Fertility Portfolio --

ATLANTA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its financial results for the second quarter of 2025.

Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference

Dr. Wenham is Principal investigator on Anixa's CAR-T therapy for Ovarian Cancer SAN JOSE, Calif., Aug. 8, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or...

- A word from our sponsors -

spot_img
HomeTagsBusiness model